LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
LMFA04010503
|
14-J4-NeuroP
|
(Z)-6-((1S,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010504
|
ent-7,14-diepi-14-J4-NeuroP
|
(Z)-6-((1S,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010505
|
7-epi-14-J4-NeuroP
|
(Z)-6-((1R,5S)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010506
|
ent-14-epi-14-J4-NeuroP
|
(Z)-6-((1R,5R)-5-((S,1E,5Z,8Z)-3-hydroxyundeca-1,5,8-trien-1-yl)-4-oxocyclopent-2-en-1-yl)hex-4-enoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010507
|
17-epi-17-J4-NeuroP
|
(4Z,7Z)-9-((1S,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010508
|
ent-10-epi-17-J4-NeuroP
|
(4Z,7Z)-9-((1S,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010509
|
10,17-diepi-17-J4-NeuroP
|
(4Z,7Z)-9-((1R,5S)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010510
|
ent-17-J4-NeuroP
|
(4Z,7Z)-9-((1R,5R)-5-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010511
|
17-J4-NeuroP
|
(4Z,7Z)-9-((1S,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010512
|
ent-10,17-diepi-17-J4-NeuroP
|
(4Z,7Z)-9-((1S,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010513
|
10-epi-17-J4-NeuroP
|
(4Z,7Z)-9-((1R,5S)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010514
|
ent-17-epi-17-J4-NeuroP
|
(4Z,7Z)-9-((1R,5R)-5-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1-yl)-4-oxocyclopent-2-en-1-yl)nona-4,7-dienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010515
|
20-epi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1S,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010516
|
ent-13-epi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1S,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010517
|
13,20-diepi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1R,5S)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010518
|
ent-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1R,5R)-5-((R,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010519
|
20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1S,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010520
|
ent-13,20-diepi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1S,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010521
|
13-epi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1R,5S)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|
LMFA04010522
|
ent-20-epi-20-J4-NeuroP
|
(4Z,7Z,10Z)-12-((1R,5R)-5-((S,E)-3-hydroxypent-1-en-1-yl)-4-oxocyclopent-2-en-1-yl)dodeca-4,7,10-trienoic acid
|
FA 22:7;O2
|
C22H30O4
|
358.214410
|